Key points from article :
Stanford University School of Medicine studied 18 patients who had suffered a stroke between six months and three years before receiving the injections.
Gary Steinberg: “At six months out from a stroke, you don’t expect to see any further recovery.”
Procedure involved injecting SB623 mesenchymal stem cells derived from bone marrow of two donors.
Substantial improvements were seen in patients’ scores on several widely accepted metrics of stroke recovery.
Improvement was independent of their age or their condition’s severity
The injected stem cells don’t survive for more than a month yet patients’ recovery is sustained for more than one year.
A new randomized phase-2b trial is now actively recruiting patients.
The study was published in the Stroke journal.
